CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 9,100 shares, a decrease of 18.8% from the May 31st total of 11,200 shares. Based on an average daily trading volume, of 49,900 shares, the short-interest ratio is currently 0.2 days.

CSL Price Performance

CSL stock traded down $0.93 during midday trading on Tuesday, reaching $97.57. 20,052 shares of the stock traded hands, compared to its average volume of 28,944. CSL has a 12 month low of $71.51 and a 12 month high of $99.95. The stock’s fifty day moving average is $93.86 and its 200-day moving average is $94.00.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.